Select edition
Country
Primary focus
Medical condition
Organization type
Stakeholder
Quality
Second Edition BOGP (0)
Canada (1)
Advocacy (policy advocacy, lobbying)
Neurology/Parkinson's Disease (1)
Think Tank (0)
Pharmaceutical companies or industry (incl. Medical device and biotech companies)
Transparency in communication and documentation
Clinical study phase I